We’re excited to share this new graphic that briefly describes who is a part of our campaign, how we work, what we do, the results, and our goal.
Categories
How Free the Vaccine for COVID-19 works
America Dissected is a Crooked Media podcast looking at the COVID-19 global pandemic.
How did we get here? What went wrong? What do we do about it now? In season 2, Dr. Abdul El-Sayed, a physician and former city health commissioner, will keep you updated on what you need to know about COVID-19, what led us to this crisis in the first place, and what policies can lead us out.
In this episode Dr. El-Sayed talks with our own Merith Basey.
Abdul dissects how COVID19 is forcing us to deal with how interconnected our world is, whether we like it or not. Then he speaks with Oussama Mezoui with the international aid organization Penny Appeal and Merith Basey of Universities Allied for Essential Medicines.
$8 Billion promised without much accountability
On the same day, a group of world leaders convened by the European Union committed over 8 billion USD to research on the COVID-19 vaccine. At the virtual event, French president Emmanuel Macron said that any vaccine developed as a result of this funding partnership “won’t belong to anybody” and that “access will be given to people around the globe.” However, EU officials clarified that pharmaceutical companies that receive any of this 8 billion USD in public funding will not be asked to forgo intellectual property rights, but simply to commit to an affordable price worldwide—which has not been clearly defined yet and may not be truly affordable, particularly in low-income countries. At the same event, the Executive Board Chair of Unitaid stated that countries need to “learn from the positive experience of the Medicines Patent Pool in making HIV treatments available to most of those who need them and support the implementation of a global voluntary pooling mechanism for Covid-19 related technologies, as proposed by World Health Organization and the President of Costa Rica.” We hope world leaders will listen, and commit to alternative intellectual property strategies that ensure affordability worldwide.
The Vaccine Alliance proposes advanced market commitment
On May 4th, Gavi proposed an advance market commitment as a strategy to ensure an adequate supply of the COVID-19 vaccine. In an advance market commitment model, governments agree in advance to buy a large quantity of a vaccine at a set price from manufacturers, avoiding shortage due to supply and demand. However, advanced market commitments are often proposed to avoid action that directly addresses affordability, and if the proposed “set price” is too high, many governments will not be able to afford the supply their people need—and taxpayers are still footing the bill. In addition, reliance on only a few manufacturers can further exacerbate the problems that monopolies cause for affordability and access. We are therefore watching the discourse around advance market commitments with caution, and hope to emphasize that these models cannot replace real guarantees of affordability.
Last week, our Lab members continued to push themselves with creative tactics to get institutions to sign on to the Open COVID Pledge. This week, they focused on learning from each other, identifying what has worked in other Labs and applying those lessons to their own projects.
MISSION 4: Identify elements that are working in other labs and apply them to your own, launch your project, and write a mission report.
Why this mission? Because:
- By identifying concrete insights from the other labs and brainstorming ways those elements could inform their strategy, participants are systematically learning from each other.
- By making sure they contact their target or identify a new one this week, the activists are creating effective and time-bound campaigns.
- By writing mission reports, participants are getting a chance to reflect on what they’ve learned and achieved, and communicating that to the rest of the group.
This week, we’d like to share some highlights from our mission reports that showcase what the Labs are working on and what they’re learning.
Jaguarundi Makes Laughter a Tactic
The Jaguarundi Lab, which is targeting two different universities in Brazil, has also adjusted their strategy for each university to create two different approaches. In targeting UFPel, which has already committed to free and non-exclusive licensing, they wrote a funny email congratulating the university on this decision and inviting them to sign the Open COVID Pledge; they plan to make this ask again on a webinar organized jointly with the university, UAEM, and DNDi.
In targeting UFMG, they circulated a petition (which now has 330 signatures) and made a play on an existing campaign to protect public universities in Brazil, adding a “no monopoly” message. They plan to deliver the message next week!
In the team’s mission report, Luciana Lopes writes that they learned
…we need to be patient, which can be really difficult. Although some initiatives don’t need a long time to be planned, some results may take some time to show up. But they will eventually. It’s a long process and every move is an important one.
Seal Plants the Seeds for Change
One of our Seal Labs has started a “Plants for COVID Research Champions” project, in which activists dedicate plants in honor of vaccine researchers as a positive way to get their attention before asking them to sign on to the Open COVID Pledge.
Of the 8 researchers they have contacted so far, 5 have responded with thanks, three of them speaking positively about transparency and data sharing in that response. In their mission report, the Seals highlight what’s working: a strategy that gets scientists to respond, a simple action with movement building appeal, and a great energy level in their squad. While they initially struggled to communicate the idea to others, creating an infographic was an easy way to ensure that the action was clear enough for others to pick up on.
In the squad’s mission report, Sofia writes that
we have been lucky to have activists in our team with connections to the access to medicines field, but we’ve still wanted more information. We need sound research about the institutes, their research lines, and partner deals. We want to be accountable, particularly now we’re inviting others to join. We hope the UK UAEM can help with this, but would also love to tap into other activist networks.
Otter Starts an Access Rivalry
Continuing work on the trading card project we told you about in previous weeks, the Otter Lab chose 3 researchers to contact at each university—USC and UCLA—with their trading cards, and an invitation to sign on to the Open COVID Pledge and become access champions. This week, they completed and sent the cards! Take a look at some examples below.
Saima Salam writes in the mission report that
commending people on the incredible COVID-19 research they are doing is always a positive way to handle a situation. Additionally, since we are providing them with customizable trading cards, it would provide an additional incentive for the researchers to hopefully sign the Open Covid Pledge. Not only are we reaching out to our top researchers but we are spreading the news through so many different outlets and as we know, starting a conversation about an issue is the first step to victory!
Before You Go
Check out this video from a Coyote member who wrote a clever parody of “What a Wonderful World,” targeting the University of Texas and AskBio. Take a listen and share it on social media if you can!
Categories
Highlights from Week 3 Mission: The Process
Last week, our Lab members began highly targeted advocacy efforts, with the goal of getting institutions to sign on to the Open COVID Pledge. This week, they continued those efforts, sharing lessons learned in order to improve strategy and push themselves strategically.
MISSION 3: Continue getting universities and other institutions to sign on to the Open COVID Pledge, while solidifying your squad and remembering that creativity counts.
Why this mission? Because:
- By continuing their efforts toward the goal we set last week, participants are using trial and error to figure out what works and applying our lab’s findings in real time.
- By pushing for new creative tactics after identifying targets and developing a strategy, participants are ensuring that they stand out and successfully engage those targets.
- By solidifying and meeting in squads, participants are setting the foundations for meaningful teamwork in the weeks ahead.
In our Global Advocacy Innovation Labs, the process matters as much as the goal. Every week, we learn from each other’s efforts and results. In that spirit, we’d like to share some highlights from this week with a focus on how our participants have been developing and modifying their strategies and tactics.
The Falcons Change Course
Last week, one Falcon squad had the idea to play on Time Magazine’s famous “Person of the Year” award with their own Photoshopped Time covers. They discussed how to best use this tactic for advocacy: could they share their Photoshopped cover calling scientists “the new Jonas Salks” as a push for researchers to aspire to and follow in Salk’s example?
Eventually, they decided to move in a new direction: creating a “Person of the Month” award given by us, on Freethevaccine.org. By honoring a scientist working on COVID-19 research, they hope to create a positive relationship, draw attention to our cause, and open the door to discussions of signing on to the Open COVID Pledge! Watch this space to see who our first honoree is.
The Dolphins Make It Personal
Last week, one of our Dolphin squads identified their target, a famous Australian immunologist, and began drafting a letter to him requesting support for the Open COVID Pledge. Not content with a generic letter, the team began an internet deep dive to learn more about the scientist and plan how they might personalize their letter. Their next draft highlighted the scientist’s own activism efforts, as well as his connection to Universities Allied for Essential Medicines—and received a response in fifteen minutes, with a promise to forward their email to the relevant people in his organization. The Dolphins then began researching the organization’s current IP policies, and sent a follow-up email to the scientist for his help finding the right contacts at his organization and other institutions in Australia. As their work shows, getting one door open with a personalized tactic has the power to open even more!
The Foxes Join Forces
Last week, one of our Fox squads identified their target as a University of Pittsburgh scientist, and started to brainstorm creative ways to reach out through poetry or photography. This week, after noticing that the university’s Center for Vaccine Research was retweeting pictures of food sent to the Center, they settled on their tactic: poetry cakes. By delivering cakes decorated with limericks calling to #FreetheVaccine, the squad hopes to show their gratitude for the scientists engaged in vaccine research while sending a positive but clear message. Now, the same Fox squad is teaming up with another Pittsburgh-affiliated team, who have been Photoshopping fake tabloid and magazine covers with fake #FreetheVaccine tattoos as a creative and public-facing way to call for a free vaccine, but were still forming a plan to connect with targets. By combining their efforts, the Fox squads hope to integrate a highly targeted tactic with one that can engage the community. Keep an eye out for pictures of the cakes and covers!
As we continue into next week, we hope to have our squads take a closer look at one another’s strategies and find concrete ways to apply lessons learned to their own efforts. Writing in our forum, Bison mentor Eric Johnson Olson reflected:
I think a big takeaway for me this week is to figure out particular people to target with different actions that play to the cost-benefit analysis. And figure out ways to shift those costs. I also loved that the Australian team played into the strengths of the researcher by asking for advice. It’s always a great way to connect with people by asking for help.
Eric Johnson Olson, Bison mentor
These are the kinds of discussions we will continue to foster as the campaign continues—note that Eric is talking about the cost-benefit analysis exercise we shared with participants in our curriculum. As we collect more insights, we’ll share them with you on this website, and we invite you to watch as our participants turn that insight into impact!
- On April 30th, Senator Warren and Representative Schakowsky announced the COVID-19 Emergency Manufacturing Act, which would require the U.S. government to begin manufacturing personal protective equipment, diagnostics and drugs in shortage, in addition to requiring the construction of manufacturing facilities for vaccines. The bill, which builds on earlier proposals by the two congresswomen, is a necessary step to ensure that the nation’s healthcare system can meet the challenge of the pandemic, and that the vaccine will be produced at the scale of public health need. As Data for Progress reported last year, voters largely support government manufacturing of drugs. Let’s hope the bill finds support in Congress too.
- A few days after the adoption of the UN resolution we shared last week, the World Health Organization launched the Access to COVID-19 Tools Accelerator, with the stated goal of ensuring that low-income and high-income countries alike will have access to the products of COVID-19 research. Unfortunately, the project has not committed to an open innovation platform or an alternative approach to intellectual property, which would be meaningful steps to make sure everyone can afford vaccines and treatment. It’s also unclear to what extent the voluntary pool we wrote positively about last week could be incorporated into this project. We’ll keep you updated as we receive more news!
Not a member of our Global Advocacy Innovation Labs? We still need your help! Here are some things you can do:
- Located In the U.S.? Sign this Petition Demanding Access.
Our U.S. Petition demands that government officials make vaccines and diagnostic tools for COVID19 developed with public funding in the U.S. available to all. If you haven’t already, please sign and share this petition— we need your solidarity and support today.
- Affiliated with a university doing COVID-19 research? Ask the department to sign the Open COVID Pledge.
This week, companies like Microsoft, IBM, HP, and Facebook joined UAEM and C4AA in supporting this pledge and urging universities and other institutions to make their intellectual property available free of charge for use in ending the COVID-19 pandemic and minimizing the impact of the disease. We need more institutions to step up and make the same commitment. Every organization working on COVID-19 should be making this pledge.
If you’re not sure how to start, our Labs have found that personalizing your message makes an enormous difference. If you have a personal connection or mutual friend with someone who has the power to sign on, reach out to them! If you don’t, do your research on potential signatories. How can you connect with them on a personal level? Be bold to make your message stand out: someone might receive dozens of emails each day, but a video or a piece of art will grab their attention.
Last week, our Lab members got our message out to a wide audience using traditional media. This week, with the goal of getting institutions to sign on to the Open COVID Pledge, we shifted gears to highly targeted creative advocacy.
MISSION 2: Get an institution to sign the Open COVID Pledge, using creative methods to reach people in power.
Why this mission? Because:
- By finding a specific individual target who can make a decision as well, and brainstorming ways to reach and persuade them that are personalized to that target, participants get a great exercise in strategic thinking.
- By using creative strategies to get an institution to sign on, participants get to break away from stale methods like open letters and try something surprising and bold.
- By asking institutions to sign onto the Open COVID Pledge, participants are working together with existing advocacy efforts instead of reinventing the wheel.
Our Innovation Lab members blew us away with their teamwork, strategic thinking, and experimentation. Read on for four different stories that showcase some of the coolest and most creative thinking that came out of the Labs this week.
A few days after we made the Open COVID Pledge the focus of our weekly mission, we received the exciting news that tech giants like Amazon, Facebook, Microsoft, IBM, and Hewlett Packard had signed the pledge. But that wasn’t the only interesting news we learned this week. Here are some developments that should be on your radar:
- The European Union introduced a draft resolution to the World Health Assembly proposing a voluntary pool for intellectual property related to COVID-19. If it passes, this could be a significant step towards ensuring access and affordability for the vaccine and treatment around the world.
- The United Nations General Assembly approved a resolution on strengthening global coordination to ensure access to diagnostics, vaccines, treatment, and personal protective equipment.
- The United States National Institutes of Health launched a public-private partnership to speed up COVID-19 vaccine and treatment development, unfortunately without any assurances for affordability.
Free the Vaccine for COVID-19 participant, L.M. Bogad, has a new podcast called The Plague. Check out episode three with Merith Basey, one of the leads of the Free The Vaccine for COVID-19 campaign.
I’m pleased to announce the launch of my podcast, THE PLAGUE. It’s a podcast where we look, not just at the ongoing coronavirus pandemic, but at our nation’s home-made plagues, plagues created by human socioeconomic systems, that make the coronavirus more virulent and dangerous.